| Year |
Citation |
Score |
| 2020 |
Grasedieck S, Ruess C, Krowiorz K, Lux S, Pochert N, Schwarzer A, Klusmann JH, Jongen-Lavrencic M, Herold T, Bullinger L, Pollack JR, Rouhi A, Kuchenbauer F. The long non-coding RNA Cancer Susceptibility 15 is induced by Isocitrate Dehydrogenase mutations and maintains an immature phenotype in adult acute myeloid leukemia. Haematologica. PMID 31896685 DOI: 10.3324/Haematol.2019.235291 |
0.32 |
|
| 2019 |
Ko YCK, Varma S, Zhu CF, Zhu SX, Vennam S, Poh CF, Jordan RC, Kong C, Pollack JR, West RB. Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland Tumors. The American Journal of Surgical Pathology. PMID 31895100 DOI: 10.1097/Pas.0000000000001421 |
0.351 |
|
| 2019 |
Li Q, Hao Q, Cao W, Li J, Wu K, Elshimali Y, Zhu D, Chen QH, Chen G, Pollack JR, Vadgama J, Wu Y. PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Science Advances. 5: eaaw8417. PMID 31663018 DOI: 10.1126/Sciadv.Aaw8417 |
0.421 |
|
| 2019 |
Middleton LW, Shen Z, Varma S, Pollack AS, Gong X, Zhu S, Zhu C, Foley JW, Vennam S, Sweeney RT, Tu K, Biscocho J, Eminaga O, Nolley R, Tibshirani R, ... ... Pollack JR, et al. Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis. Jci Insight. 5. PMID 31094703 DOI: 10.1172/Jci.Insight.129749 |
0.337 |
|
| 2019 |
Saffari PS, Vapniarsky N, Pollack AS, Gong X, Vennam S, Pollack AJ, Verstraete FJM, West RB, Arzi B, Pollack JR. Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer. Oncogenesis. 8: 11. PMID 30741938 DOI: 10.1038/s41389-019-0119-1 |
0.326 |
|
| 2018 |
Andreasen S, Varma S, Barasch N, Thompson LDR, Miettinen M, Rooper L, Stelow EB, Agander TK, Seethala RR, Chiosea SI, Homøe P, Wessel I, Larsen SR, Erentaite D, Bishop JA, ... ... Pollack JR, et al. The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland. The American Journal of Surgical Pathology. PMID 30520817 DOI: 10.1097/Pas.0000000000001200 |
0.38 |
|
| 2018 |
Davidson J, Shen Z, Gong X, Pollack JR. SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents. Oncotarget. 9: 9608-9617. PMID 29515757 DOI: 10.18632/Oncotarget.20033 |
0.404 |
|
| 2018 |
Kumar R, Kotapalli V, Naz A, Gowrishankar S, Rao S, Pollack JR, Dharan Bashyam M. XPNPEP3 is a novel transcriptional target of canonical Wnt/β-catenin signalling. Genes, Chromosomes & Cancer. PMID 29383790 DOI: 10.1002/Gcc.22531 |
0.379 |
|
| 2018 |
Grasedieck S, Rueß C, Pochert N, Lux S, Schwarzer A, Klusmann J, Jongen-Lavrencic M, Pollack JR, Rouhi A, Kuchenbauer F. Identification of Novel Lncrnas That Predict Survival in AML Patients and Modulate Leukemic Cells Blood. 132: 3909-3909. DOI: 10.1182/Blood-2018-99-118331 |
0.386 |
|
| 2018 |
Kumar R, Naz A, Kotapalli V, Gowrishankar S, Rao S, Pollack JR, Bashyam MD. Abstract 5438: XPNPEP3: A novel transcriptional target of canonical Wnt/β-catenin signalling Cancer Research. 78: 5438-5438. DOI: 10.1158/1538-7445.Am2018-5438 |
0.436 |
|
| 2017 |
Kwon MJ, Kim RN, Song K, Jeon S, Jeong HM, Kim JS, Han J, Hong S, Oh E, Choi JS, An J, Pollack JR, Choi YL, Park CK, Shin YK. Genes co-amplified with ERBB2 or MET as novel potential cancer-promoting genes in gastric cancer. Oncotarget. 8: 92209-92226. PMID 29190909 DOI: 10.18632/Oncotarget.21150 |
0.485 |
|
| 2017 |
Kumar R, Raman R, Kotapalli V, Gowrishankar S, Pyne S, Pollack JR, Bashyam MD. Ca(2+)/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation. Journal of Molecular Medicine (Berlin, Germany). PMID 29124284 DOI: 10.1007/S00109-017-1607-4 |
0.445 |
|
| 2017 |
Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer. Oncotarget. 8: 18657-18669. PMID 28423633 DOI: 10.18632/Oncotarget.15703 |
0.453 |
|
| 2017 |
Barasch N, Gong X, Kwei KA, Varma S, Biscocho J, Qu K, Xiao N, Lipsick JS, Pelham RJ, West RB, Pollack JR. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma. Plos One. 12: e0171265. PMID 28212443 DOI: 10.1371/Journal.Pone.0171265 |
0.43 |
|
| 2017 |
Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Abstract 4721: Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer Cancer Research. 77: 4721-4721. DOI: 10.1158/1538-7445.Am2017-4721 |
0.441 |
|
| 2017 |
Shen Z, Davidson J, Pollack J. Abstract 3809: SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents Cancer Research. 77: 3809-3809. DOI: 10.1158/1538-7445.Am2017-3809 |
0.379 |
|
| 2017 |
Ko YC, Zhu C, Zhu S, Vennam S, Jordan RC, Pollack J, West R. Gene Expression Profile Of Ameloblastoma Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 124. DOI: 10.1016/J.Oooo.2017.06.022 |
0.348 |
|
| 2016 |
Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, et al. Loss of expression of AZGP1 is associated with worse clinical outcomes in a multi-institutional radical prostatectomy cohort. The Prostate. PMID 27325561 DOI: 10.1002/Pros.23225 |
0.318 |
|
| 2015 |
Clarke N, Biscocho J, Kwei KA, Davidson JM, Sridhar S, Gong X, Pollack JR. Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer. Plos One. 10: e0142061. PMID 26556242 DOI: 10.1371/Journal.Pone.0142061 |
0.414 |
|
| 2015 |
Malik S, Villanova L, Tanaka S, Aonuma M, Roy N, Berber E, Pollack JR, Michishita-Kioi E, Chua KF. SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors. Scientific Reports. 5: 9841. PMID 25923013 DOI: 10.1038/Srep09841 |
0.498 |
|
| 2015 |
Gong X, Pollack J, Brooks JD. Abstract A1-70: Klip1 lincRNA is a prognostic biomarker for clear cell renal cell carcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-70 |
0.456 |
|
| 2014 |
Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, ... ... Pollack JR, et al. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nature Genetics. 46: 722-5. PMID 24859340 DOI: 10.1038/Ng.2986 |
0.301 |
|
| 2014 |
Raman R, Kotapalli V, Adduri R, Gowrishankar S, Bashyam L, Chaudhary A, Vamsy M, Patnaik S, Srinivasulu M, Sastry R, Rao S, Vasala A, Kalidindi N, Pollack J, Murthy S, et al. Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India. Molecular Carcinogenesis. 53: E181-6. PMID 23168910 DOI: 10.1002/Mc.21976 |
0.325 |
|
| 2014 |
Lin AY, Kouzminova NB, Pollack J, Nuovo G. Prognostic role of microRNA-34a expression in colorectal cancer. Journal of Clinical Oncology. 32: 472-472. DOI: 10.1200/Jco.2014.32.3_Suppl.472 |
0.391 |
|
| 2014 |
Lin AY, Kouzminova NB, Pollack J, Nuovo G. Prognostic and predictive value of microRNA-34a expression in colorectal cancer. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E22045 |
0.418 |
|
| 2014 |
McClary AC, Sweeney RT, Biscocho J, Myers BR, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Rubin B, Troxell ML, Pelham RJ, ... ... Pollack JR, et al. Abstract 3436: Ameloblastoma driver mutations revealed by next-generation sequencing of formalin-fixed paraffin-embedded specimens Cancer Research. 74: 3436-3436. DOI: 10.1158/1538-7445.Am2014-3436 |
0.391 |
|
| 2013 |
Shain AH, Salari K, Giacomini CP, Pollack JR. Integrative genomic and functional profiling of the pancreatic cancer genome. Bmc Genomics. 14: 624. PMID 24041470 DOI: 10.1186/1471-2164-14-624 |
0.442 |
|
| 2013 |
Cuff J, Salari K, Clarke N, Esheba GE, Forster AD, Huang S, West RB, Higgins JP, Longacre TA, Pollack JR. Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. Plos One. 8: e74562. PMID 24040285 DOI: 10.1371/Journal.Pone.0074562 |
0.398 |
|
| 2013 |
Khursheed M, Kolla JN, Kotapalli V, Gupta N, Gowrishankar S, Uppin SG, Sastry RA, Koganti S, Sundaram C, Pollack JR, Bashyam MD. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines. British Journal of Cancer. 108: 2056-62. PMID 23660946 DOI: 10.1038/Bjc.2013.200 |
0.383 |
|
| 2013 |
Giacomini CP, Sun S, Varma S, Shain AH, Giacomini MM, Balagtas J, Sweeney RT, Lai E, Del Vecchio CA, Forster AD, Clarke N, Montgomery KD, Zhu S, Wong AJ, van de Rijn M, ... ... Pollack JR, et al. Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. Plos Genetics. 9: e1003464. PMID 23637631 DOI: 10.1371/Journal.Pgen.1003464 |
0.518 |
|
| 2013 |
Shain AH, Pollack JR. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. Plos One. 8: e55119. PMID 23355908 DOI: 10.1371/Journal.Pone.0055119 |
0.396 |
|
| 2013 |
Del Vecchio CA, Giacomini CP, Vogel H, Jensen KC, Florio T, Merlo A, Pollack JR, Wong AJ. EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms. Oncogene. 32: 2670-81. PMID 22797070 DOI: 10.1038/Onc.2012.280 |
0.332 |
|
| 2013 |
Raman R, Kotapalli V, Adduri RS, Bhaskara VK, Gowrishankar S, Bashyam L, Chaudhary A, Chigurupati MV, Patnaik S, Srinivasulu M, Sastry R, Rao S, Vasala A, Kalidindi N, Pollack J, et al. Abstract 1198: Presence of non-canonical tumorigenesis pathways in early-onset sporadic rectal cancer. Cancer Research. 73: 1198-1198. DOI: 10.1158/1538-7445.Am2013-1198 |
0.47 |
|
| 2012 |
Salari K, Spulak ME, Cuff J, Forster AD, Giacomini CP, Huang S, Ko ME, Lin AY, van de Rijn M, Pollack JR. CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: E3196-205. PMID 23112155 DOI: 10.1073/Pnas.1206004109 |
0.477 |
|
| 2012 |
Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biology. 13: R75. PMID 22929540 DOI: 10.1186/Gb-2012-13-8-R75 |
0.403 |
|
| 2012 |
Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR. Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: E252-9. PMID 22233809 DOI: 10.1073/Pnas.1114817109 |
0.482 |
|
| 2012 |
Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack JR. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene. 31: 4164-4170. PMID 22179824 DOI: 10.1038/Onc.2011.590 |
0.429 |
|
| 2012 |
Chung JL, Pollack J, Chua M, So S, Lin C, Lin AY. Identification of a 14-gene signature that predicts survival in colorectal cancer with liver metastasis. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E14037 |
0.375 |
|
| 2012 |
Vecchio CAD, Giacomini CP, Vogel H, Jensen KC, Florio T, Merlo A, Pollack JR, Wong AJ. Abstract 10: Oncogenic variant EGFRvIII defines a hierarchy in glioblastoma and expression is restricted by epigenetic mechanisms despite the presence of gene amplification Cancer Research. 72: 10-10. DOI: 10.1158/1538-7445.Am2012-10 |
0.453 |
|
| 2011 |
Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD, Pollack JR. SMURF1 amplification promotes invasiveness in pancreatic cancer. Plos One. 6: e23924. PMID 21887346 DOI: 10.1371/Journal.Pone.0023924 |
0.488 |
|
| 2011 |
Nowak G, Hastie T, Pollack JR, Tibshirani R. A fused lasso latent feature model for analyzing multi-sample aCGH data. Biostatistics (Oxford, England). 12: 776-91. PMID 21642389 DOI: 10.1093/Biostatistics/Kxr012 |
0.313 |
|
| 2011 |
Malhotra S, Lapointe J, Salari K, Higgins JP, Ferrari M, Montgomery K, van de Rijn M, Brooks JD, Pollack JR. A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. Plos One. 6: e20293. PMID 21629784 DOI: 10.1371/Journal.Pone.0020293 |
0.405 |
|
| 2011 |
Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK, Pollack JR. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. Plos One. 6: e16636. PMID 21383983 DOI: 10.1371/Journal.Pone.0016636 |
0.393 |
|
| 2011 |
Shain AH, Matsukuma K, Giacomini C, Karikari CA, Hidalgo M, Maitra A, Pollack JR. Abstract 3930: Integrative genomic analysis reveals SWI/SNF chromatin remodeling complex to be a TGFβ-mediating tumor suppressor pathway in pancreatic cancer Cancer Research. 71: 3930-3930. DOI: 10.1158/1538-7445.Am2011-3930 |
0.46 |
|
| 2010 |
Peng J, Zhu J, Bergamaschi A, Han W, Noh DY, Pollack JR, Wang P. Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer. The Annals of Applied Statistics. 4: 53-77. PMID 24489618 DOI: 10.1214/09-AOAS271SUPP |
0.382 |
|
| 2010 |
Cai D, Shames DS, Raso MG, Xie Y, Kim YH, Pollack JR, Girard L, Sullivan JP, Gao B, Peyton M, Nanjundan M, Byers L, Heymach J, Mills G, Gazdar AF, et al. Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation. Cancer Research. 70: 6477-85. PMID 20663904 DOI: 10.1158/0008-5472.Can-10-0005 |
0.474 |
|
| 2010 |
Tseng WW, Winer D, Kenkel JA, Choi O, Shain AH, Pollack JR, French R, Lowy AM, Engleman EG. Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3684-95. PMID 20534740 DOI: 10.1158/1078-0432.Ccr-09-2384 |
0.374 |
|
| 2010 |
Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR. Genomic instability in breast cancer: pathogenesis and clinical implications. Molecular Oncology. 4: 255-66. PMID 20434415 DOI: 10.1016/J.Molonc.2010.04.001 |
0.512 |
|
| 2010 |
Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Research. 70: 2296-306. PMID 20215510 DOI: 10.1158/0008-5472.Can-09-3141 |
0.778 |
|
| 2010 |
Lück SC, Russ AC, Du J, Gaidzik V, Schlenk RF, Pollack JR, Döhner K, Döhner H, Bullinger L. KIT mutations confer a distinct gene expression signature in core binding factor leukaemia: Research paper British Journal of Haematology. 148: 925-937. PMID 20064158 DOI: 10.1111/J.1365-2141.2009.08035.X |
0.351 |
|
| 2010 |
Salari K, Tibshirani R, Pollack JR. DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data. Bioinformatics (Oxford, England). 26: 414-6. PMID 20031972 DOI: 10.1093/Bioinformatics/Btp702 |
0.377 |
|
| 2010 |
Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J, Langerød A, Han W, Noh DY, Jeffrey SS, Huntsman DG, Børresen-Dale AL, Pollack JR. Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene. 29: 774-9. PMID 19881546 DOI: 10.1038/Onc.2009.364 |
0.773 |
|
| 2010 |
Peng J, Zhu J, Bergamaschi A, Han W, Noh DY, Pollack JR, Wang P. Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer The Annals of Applied Statistics. 4: 53-77. DOI: 10.1214/09-Aoas271 |
0.475 |
|
| 2010 |
Salari K, Cuff J, Giacomini CP, Lin A, Rijn Mvd, Pollack JR. Abstract 2130: Genomic profiling identifies CDX2 as a lineage-dependent oncogene amplified in colorectal cancer Cancer Research. 70: 2130-2130. DOI: 10.1158/1538-7445.Am10-2130 |
0.49 |
|
| 2009 |
Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer. Oncogene. 29: 1421-30. PMID 19966867 DOI: 10.1038/Onc.2009.437 |
0.484 |
|
| 2009 |
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. Plos One. 4: e6146. PMID 19582160 DOI: 10.1371/Journal.Pone.0006146 |
0.776 |
|
| 2009 |
Salari K, Pollack JR. Integration of diverse microarray data types. Methods in Molecular Biology (Clifton, N.J.). 556: 205-16. PMID 19488881 DOI: 10.1007/978-1-60327-192-9_15 |
0.322 |
|
| 2009 |
Kim YH, Pollack JR. Comparative genomic hybridization on spotted oligonucleotide microarrays. Methods in Molecular Biology (Clifton, N.J.). 556: 21-32. PMID 19488869 DOI: 10.1007/978-1-60327-192-9_3 |
0.33 |
|
| 2008 |
Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerød A, Han W, Noh DY, Huntsman DG, Jeffrey SS, Børresen-Dale AL, Pollack JR. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Molecular Oncology. 2: 327-39. PMID 19383354 DOI: 10.1016/J.Molonc.2008.09.004 |
0.783 |
|
| 2008 |
Horlings HM, Bergamaschi A, Nordgard SH, Kim YH, Han W, Noh DY, Salari K, Joosse SA, Reyal F, Lingjaerde OC, Kristensen VN, Børresen-Dale AL, Pollack J, van de Vijver MJ. ESR1 gene amplification in breast cancer: a common phenomenon? Nature Genetics. 40: 807-8; author reply . PMID 18583965 DOI: 10.1038/ng0708-807 |
0.438 |
|
| 2008 |
Kwei KA, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, ... ... Pollack JR, et al. Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. Plos Genetics. 4: e1000081. PMID 18535672 DOI: 10.1371/Journal.Pgen.1000081 |
0.546 |
|
| 2008 |
Thompson M, Lapointe J, Choi YL, Ong DE, Higgins JP, Brooks JD, Pollack JR. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle. The Prostate. 68: 1248-56. PMID 18500686 DOI: 10.1002/Pros.20792 |
0.365 |
|
| 2008 |
Bullinger L, Döhner K, Kranz R, Stirner C, Fröhling S, Seholl C, Kim YH, Schlenk RF, Tibshirani R, Döhner H, Pollack JR. An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML Blood. 111: 4490-4495. PMID 18309032 DOI: 10.1182/Blood-2007-09-115055 |
0.38 |
|
| 2008 |
Lapointe J, Malhotra S, Higgins JP, Bair E, Thompson M, Salari K, Giacomini CP, Ferrari M, Montgomery K, Tibshirani R, van de Rijn M, Brooks JD, Pollack JR. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. The American Journal of Surgical Pathology. 32: 205-9. PMID 18223322 DOI: 10.1097/Pas.0B013E318124A865 |
0.39 |
|
| 2008 |
Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K, Lee J, Choi YL, Sato M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene. 27: 3635-40. PMID 18212743 DOI: 10.1038/Sj.Onc.1211012 |
0.448 |
|
| 2008 |
Dumur CI, Lyons-Weiler M, Sciulli C, Garrett CT, Schrijver I, Holley TK, Rodriguez-Paris J, Pollack JR, Zehnder JL, Price M, Hagenkord JM, Rigl CT, Buturovic LJ, Anderson GG, Monzon FA. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. The Journal of Molecular Diagnostics : Jmd. 10: 67-77. PMID 18083688 DOI: 10.2353/Jmoldx.2008.070099 |
0.387 |
|
| 2008 |
Bullinger L, Hielscher T, Botzenhardt U, Heinrich S, Schlenk R, Pollack JR, Dohner K, Benner A, Dohner H. Impact of Gene Expression Profiling on Diagnosis and Prognostication in Cytogenetically Normal AML. Blood. 112: 1487-1487. DOI: 10.1182/Blood.V112.11.1487.1487 |
0.404 |
|
| 2007 |
Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, Ferrari M, Hernandez-Boussard T, Brooks JD, Pollack JR. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Research. 67: 8504-10. PMID 17875689 DOI: 10.1158/0008-5472.Can-07-0673 |
0.449 |
|
| 2007 |
Dumas L, Kim YH, Karimpour-Fard A, Cox M, Hopkins J, Pollack JR, Sikela JM. Gene copy number variation spanning 60 million years of human and primate evolution. Genome Research. 17: 1266-77. PMID 17666543 DOI: 10.1101/Gr.6557307 |
0.346 |
|
| 2007 |
Pollack JR. A perspective on DNA microarrays in pathology research and practice. The American Journal of Pathology. 171: 375-85. PMID 17600117 DOI: 10.2353/Ajpath.2007.070342 |
0.301 |
|
| 2007 |
Bullinger L, Rücker FG, Kurz S, Du J, Scholl C, Sander S, Corbacioglu A, Lottaz C, Krauter J, Fröhling S, Ganser A, Schlenk RF, Döhner K, Pollack JR, Döhner H. Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia. Blood. 110: 1291-300. PMID 17485551 DOI: 10.1182/Blood-2006-10-049783 |
0.376 |
|
| 2007 |
Lapointe J, Kim YH, Miller MA, Li C, Kaygusuz G, van de Rijn M, Huntsman DG, Brooks JD, Pollack JR. A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 467-73. PMID 17334351 DOI: 10.1038/Modpathol.3800759 |
0.395 |
|
| 2007 |
Beaty RM, Gronborg M, Pollack JR, Maitra A. Target discovery and validation in pancreatic cancer. Methods in Molecular Biology (Clifton, N.J.). 360: 57-89. PMID 17172725 DOI: 10.1385/1-59745-165-7:57 |
0.446 |
|
| 2007 |
Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, Ma L, Hanna AE, Liu D, Girard L, Kim YH, Pollack JR, Minna JD, Wistuba II, Kurie JM. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene. 26: 2658-66. PMID 17057737 DOI: 10.1038/Sj.Onc.1210050 |
0.353 |
|
| 2007 |
Lin AY, Chua M, Choi YL, Yeh W, Kim YH, Azzi R, So SK, Pollack JR. Identification of prognostically-relevant signature genes differentially expressed between primary colorectal carcinoma and hepatic metastasis Journal of Clinical Oncology. 25: 4116-4116. DOI: 10.1200/Jco.2007.25.18_Suppl.4116 |
0.414 |
|
| 2006 |
Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. Plos Medicine. 3: e486. PMID 17194187 DOI: 10.1371/Journal.Pmed.0030486 |
0.477 |
|
| 2006 |
Li S, Bhamre S, Lapointe J, Pollack JR, Brooks JD. Application of genomic technologies to human prostate cancer. Omics : a Journal of Integrative Biology. 10: 261-75. PMID 17069507 DOI: 10.1089/Omi.2006.10.261 |
0.378 |
|
| 2006 |
Pollack JR. Chromosome instability leaves its mark. Nature Genetics. 38: 973-4. PMID 16941002 DOI: 10.1038/Ng0906-973 |
0.418 |
|
| 2006 |
Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L. Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches Blood. 108: 4109-4117. PMID 16931630 DOI: 10.1182/Blood-2006-01-023127 |
0.311 |
|
| 2006 |
Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes & Cancer. 45: 1033-40. PMID 16897746 DOI: 10.1002/Gcc.20366 |
0.575 |
|
| 2006 |
Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C, Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR, Lichter P, Döhner K, et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3887-94. PMID 16864856 DOI: 10.1200/Jco.2005.04.5450 |
0.375 |
|
| 2006 |
Rücker FG, Sander S, Döhner K, Döhner H, Pollack JR, Bullinger L. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia. 20: 994-1001. PMID 16721385 DOI: 10.1038/Sj.Leu.2404235 |
0.403 |
|
| 2006 |
Kao J, Pollack JR. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes, Chromosomes & Cancer. 45: 761-9. PMID 16708353 DOI: 10.1002/Gcc.20339 |
0.596 |
|
| 2006 |
Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecologic Oncology. 100: 264-70. PMID 16236351 DOI: 10.1016/J.Ygyno.2005.08.026 |
0.504 |
|
| 2006 |
Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification Oncogene. 25: 130-138. PMID 16116477 DOI: 10.1038/Sj.Onc.1208997 |
0.431 |
|
| 2006 |
Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Dohner K, Schmitt A, Schlenk RF, Pollack JR, Dohner H, Bullinger L. Expression of Tumor-Associated Antigens (TAAs) in Acute Myeloid Leukemia (AML) Correlated with Specific T Cell Responses and Survival. Blood. 108: 414-414. DOI: 10.1182/Blood.V108.11.414.414 |
0.315 |
|
| 2006 |
Bullinger L, Dohner K, Schlenk RF, Rucker FG, Pollack JR, Dohner H, Schmid M. In Vitro and In Vivo Monitoring of Valproic Acid Effects on Gene Expression Signatures in Adult Acute Myeloid Leukemia. Blood. 108: 2605-2605. DOI: 10.1182/Blood.V108.11.2605.2605 |
0.423 |
|
| 2006 |
Bullinger L, Dohner K, Stirner C, Rucker FG, Frohling S, Kim YH, Schlenk RF, Tibshirani R, Dohner H, Pollack JR. A FLT3 Gene-Expression Signature Outperforms FLT3 Status in Predicting Clinical Outcome for Patients with Normal Karyotype AML. Blood. 108: 2311-2311. DOI: 10.1182/Blood.V108.11.2311.2311 |
0.37 |
|
| 2006 |
Bullinger L, Dohner K, Kranz R, Rucker FG, Frohling S, Schlenk RF, Pollack JR, Dohner H. Characterization of NPM1 -Mutated/ FLT3 ITD-Negative Acute Myeloid Leukemia with Normal Karyotype by Gene Expression Profiling. Blood. 108: 155-155. DOI: 10.1182/Blood.V108.11.155.155 |
0.357 |
|
| 2005 |
Giacomini CP, Leung SY, Chen X, Yuen ST, Kim YH, Bair E, Pollack JR. A gene expression signature of genetic instability in colon cancer. Cancer Research. 65: 9200-5. PMID 16230380 DOI: 10.1158/0008-5472.Can-04-4163 |
0.506 |
|
| 2005 |
Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, van de Rijn M, Brooks JD, Pollack JR. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Research. 65: 8118-24. PMID 16166285 DOI: 10.1158/0008-5472.Can-04-4562 |
0.39 |
|
| 2005 |
Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JR. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia (New York, N.Y.). 7: 556-62. PMID 16036106 DOI: 10.1593/Neo.04586 |
0.431 |
|
| 2005 |
Bullinger L, Döner H, Pollack JR. Genomics in myeloid leukemias: an array of possibilities Reviews in Clinical and Experimental Hematology.. 9: E2. PMID 16027104 |
0.3 |
|
| 2005 |
Sander S, Bullinger L, Karlsson A, Giuriato S, Hernandez-Boussard T, Felsher DW, Pollack JR. Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model Oncogene. 24: 6101-6107. PMID 16007205 DOI: 10.1038/Sj.Onc.1208751 |
0.44 |
|
| 2005 |
Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research. 65: 4031-40. PMID 15899792 DOI: 10.1158/0008-5472.Can-04-3617 |
0.412 |
|
| 2005 |
Bredel M, Bredel C, Juric D, Kim Y, Vogel H, Harsh GR, Recht LD, Pollack JR, Sikic BI. Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. The Journal of Molecular Diagnostics : Jmd. 7: 171-82. PMID 15858140 DOI: 10.1016/S1525-1578(10)60543-0 |
0.375 |
|
| 2005 |
Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, Sethuraman A, van de Rijn M, Botstein D, Brown PO, Pollack JR. A DNA microarray survey of gene expression in normal human tissues. Genome Biology. 6: R22. PMID 15774023 DOI: 10.1186/Gb-2005-6-3-R22 |
0.388 |
|
| 2005 |
Wang P, Kim Y, Pollack J, Narasimhan B, Tibshirani R. A method for calling gains and losses in array CGH data. Biostatistics (Oxford, England). 6: 45-58. PMID 15618527 DOI: 10.1093/Biostatistics/Kxh017 |
0.339 |
|
| 2005 |
Zhao H, Kim Y, Wang P, Lapointe J, Tibshirani R, Pollack JR, Brooks JD. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. The Prostate. 63: 187-97. PMID 15486987 DOI: 10.1002/Pros.20158 |
0.463 |
|
| 2005 |
Helland Å, Nicolau M, Ji Y, Langerød A, Sommervoll D, Bergamaschi A, Pollack J, Børresen-Dale A, Jeffrey S. TP53 mutations among molecular subtypes of HER2-positive tumors Breast Cancer Research. 7. DOI: 10.1186/Bcr1175 |
0.313 |
|
| 2005 |
Bullinger L, Bair E, Kranz R, Dohner K, Frohling S, Schlenk RF, Tibshirani R, Dohner H, Pollack JR. Prognostic Gene-Expression Signatures in Adult Acute Myeloid Leukemia with Normal Karyotype. Blood. 106: 756-756. DOI: 10.1182/Blood.V106.11.756.756 |
0.379 |
|
| 2005 |
Rucker FG, Sander S, Dohner K, Dohner H, Pollack JR, Bullinger L. Array-CGH and Gene Expression Profiling Based Molecular Characterization of Myeloid Leukemia Cell Lines. Blood. 106: 4397-4397. DOI: 10.1182/Blood.V106.11.4397.4397 |
0.429 |
|
| 2004 |
Fortna A, Kim Y, MacLaren E, Marshall K, Hahn G, Meltesen L, Brenton M, Hink R, Burgers S, Hernandez-Boussard T, Karimpour-Fard A, Glueck D, McGavran L, Berry R, Pollack J, et al. Lineage-specific gene duplication and loss in human and great ape evolution. Plos Biology. 2: E207. PMID 15252450 DOI: 10.1371/Journal.Pbio.0020207 |
0.357 |
|
| 2004 |
Harvell JD, Kohler S, Zhu S, Hernandez-Boussard T, Pollack JR, van de Rijn M. High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas. Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. 13: 22-5. PMID 15163005 DOI: 10.1097/00019606-200403000-00004 |
0.337 |
|
| 2004 |
Bullinger L, Döhner K, Bair E, Fröhling S, Schlenk RF, Tibshirani R, Döhner H, Pollack JR. Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia New England Journal of Medicine. 350: 1605-1616. PMID 15084693 DOI: 10.1056/Nejmoa031046 |
0.325 |
|
| 2004 |
Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, ... ... Pollack JR, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 101: 811-6. PMID 14711987 DOI: 10.1073/Pnas.0304146101 |
0.405 |
|
| 2004 |
Bullinger L, Scholl C, Bair E, Dohner K, Frohling S, Schlenk RF, Tibshirani R, Dohner H, Pollack JR. Identification of Distinct inv(16) Subclasses in Adult Acute Myeloid Leukemia Based on Gene Expression Profiling. Blood. 104: 2037-2037. DOI: 10.1182/Blood.V104.11.2037.2037 |
0.408 |
|
| 2003 |
Linn SC, West RB, Pollack JR, Zhu S, Hernandez-Boussard T, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Siegmund D, Botstein D, Brown PO, Gilks CB, van de Rijn M. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. The American Journal of Pathology. 163: 2383-95. PMID 14633610 DOI: 10.1016/S0002-9440(10)63593-6 |
0.412 |
|
| 2003 |
Jeffrey SS, Pollack JR. The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Research : Bcr. 5: 320-8. PMID 14580250 DOI: 10.1186/Bcr655 |
0.49 |
|
| 2003 |
Pollack JR. Parallel analysis of gene copy number and expression using cDNA microarrays. Methods in Molecular Biology (Clifton, N.J.). 224: 89-97. PMID 12710668 DOI: 10.1385/1-59259-364-X:89 |
0.354 |
|
| 2003 |
Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. The American Journal of Pathology. 162: 925-32. PMID 12598325 DOI: 10.1016/S0002-9440(10)63887-4 |
0.375 |
|
| 2002 |
Pollack JR, Iyer VR. Characterizing the physical genome. Nature Genetics. 32: 515-21. PMID 12454647 DOI: 10.1038/Ng1035 |
0.321 |
|
| 2002 |
Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences of the United States of America. 99: 12963-8. PMID 12297621 DOI: 10.1073/Pnas.162471999 |
0.519 |
|
| 2002 |
Willert J, Epping M, Pollack JR, Brown PO, Nusse R. A transcriptional response to Wnt protein in human embryonic carcinoma cells. Bmc Developmental Biology. 2: 8. PMID 12095419 DOI: 10.1186/1471-213X-2-8 |
0.392 |
|
| 2002 |
Lin JY, Pollack JR, Chou FL, Rees CA, Christian AT, Bedford JS, Brown PO, Ginsberg MH. Physical mapping of genes in somatic cell radiation hybrids by comparative genomic hybridization to cDNA microarrays. Genome Biology. 3: RESEARCH0026. PMID 12093373 DOI: 10.1186/Gb-2002-3-6-Research0026 |
0.373 |
|
| 2002 |
Pollack JR, Van de Rijn M, Botstein D. Challenges in developing a molecular characterization of cancer. Seminars in Oncology. 29: 280-5. PMID 12063681 DOI: 10.1053/Sonc.2002.32903 |
0.483 |
|
| 2002 |
Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet (London, England). 359: 1301-7. PMID 11965276 DOI: 10.1016/S0140-6736(02)08270-3 |
0.371 |
|
| 2000 |
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, et al. Molecular portraits of human breast tumours. Nature. 406: 747-52. PMID 10963602 DOI: 10.1038/35021093 |
0.453 |
|
| 1999 |
Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genetics. 23: 41-6. PMID 10471496 DOI: 10.1038/12640 |
0.394 |
|
| 1999 |
Pollack JR, Perou CM, Sorlie T, Alizadeh AA, Rees C, Eise MB, Pergamenschikov A, Williams CF, van de Rijn M, Jeffrey SS, Johnsen H, Lonning PE, Geisler S, Aas T, Borresen-Dale A, et al. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays Nature Genetics. 23: 69-69. DOI: 10.1038/14385 |
0.453 |
|
| Show low-probability matches. |